# USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19

> **NCT04425850** · — · COMPLETED · sponsor: **Eurnekian Public Hospital** · enrollment: 229 (actual)

## Conditions studied

- Covid19

## Interventions

- **COMBINATION_PRODUCT:** Iota carrageenan nasal spray and Ivermectin oral drops (used as buccal drops)

## Key facts

- **NCT ID:** NCT04425850
- **Lead sponsor:** Eurnekian Public Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2020-08-10
- **Final completion:** 2020-08-10
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04425850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04425850, "USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04425850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*